FFA
EDIT icon

Farther Finance Advisors’s Editas Medicine EDIT Stock Holding History

Farther Finance Advisors’s Portfolio EDIT Stock Details EDIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$195 Sell
76
-577
-88% -$1.69K ﹤0.01% 5884
2026
Q2 		$2.11K Sell
653
-1,002
-61% -$2.93K ﹤0.01% 5153
2026
Q1 		$4.32K Buy
1,655
+517
+45% +$1.09K ﹤0.01% 4566
2025
Q4 		$2.33K Hold
1,138
– – ﹤0.01% 4633
2025
Q3 		$3.95K Buy
+1,138
New +$3.18K ﹤0.01% 3866
2025
Q2 		– Sell
-106
Closed -$120 – 4539
2025
Q1 		$120 Sell
106
-120
-53% -$177 ﹤0.01% 4045
2024
Q4 		$287 Buy
+226
New +$576 ﹤0.01% 3567
2024
Q3 		– Sell
-10
Closed -$46 – 4037
2024
Q2 		$46 Hold
10
– – ﹤0.01% 3699
2024
Q1 		$73 Sell
10
-1
-9% -$8 ﹤0.01% 3421
2023
Q4 		$111 Buy
+11
New +$97 ﹤0.01% 3290

Other funds holding EDIT

GAA
Green Alpha Advisors Niwot, Colorado $148M AUM 98.22% 1-Year Est. Return
DIM
DLK Investment Management Solana Beach, California $275M AUM 10.69% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 19.15% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.79B AUM 19.33% 1-Year Est. Return
VCM
Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return

Farther Finance Advisors's EDIT Position: Q3 2026 in Review

Farther Finance Advisors reduced its Editas Medicine (EDIT) stake by 88% in Q3 2026, selling an estimated $1.69K and leaving 76 shares worth $195. The position accounts for ﹤0.01% of the portfolio, ranked #5884.

Farther Finance Advisors first reported a position in EDIT in Q4 2023 and has held it in 10 quarters since. The position peaked at $4.32K in Q1 2026. 7 funds tracked by Wall St. Rank hold EDIT as of Q3 2026.

  • Farther Finance Advisors held 76 shares of Editas Medicine worth $195 as of Q3 2026.
  • Farther Finance Advisors sold 577 Editas Medicine shares in Q3 2026, an estimated $1.69K.
  • Editas Medicine made up ﹤0.01% of Farther Finance Advisors's portfolio in Q3 2026, its #5884 holding.
  • Farther Finance Advisors first reported a position in Editas Medicine in Q4 2023 and has held it in 10 quarters since.
  • Farther Finance Advisors's Editas Medicine position peaked at $4.32K in Q1 2026.
  • 7 funds tracked by Wall St. Rank held Editas Medicine as of Q3 2026.

Based on Farther Finance Advisors's 13F filing for Q3 2026, filed 8 Oct 2026.